Robot-Assisted surgery for pelvic organ prolapse shows promise in small study

NCT ID NCT07031050

Completed Disease control Sponsor: Distalmotion SA Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested the safety and effectiveness of a new robotic system (Dexter) for repairing pelvic organ prolapse in 35 women. The surgery aimed to restore support to the pelvic organs using a robot-assisted approach. The main goals were to see if the procedure could be completed without switching to open or standard laparoscopic surgery, and to track any serious complications within the first six weeks after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dexter robotic surgery system
What this could lead to: If successful, this could confirm that the Dexter robotic system is a safe and effective tool for performing pelvic organ prolapse surgery.
What could go wrong: This is a small, completed observational study with only 35 participants and no comparison group. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PELVIC ORGAN PROLAPSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pelvic organ prolapse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SACROCOLPOPEXY

Contacts and locations

Locations

Charité - Universitätsmedizin Berlin

Berlin, Germany
Inselspital Bern

Bern, Switzerland
Krankenhaus St. Elisabeth

Damme, Germany
Spitäler FMI AG

Interlaken, Switzerland
Universitätsklinikum Bonn

Bonn, Germany
Universitätsmedizin Essen

Essen, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.